A Study to Evaluate Safety of Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis

Ichinomiya-shi, Aichi-ken 491-8558, Japan

Nagoya, Aichi-ken 464-0821, Japan

Nagoya, Aichi-ken 467-8602, Japan

Chikushino-shi, Fukuoka 818-0083, Japan

Fukuoka, Fukuoka 813-0044, Japan

Fukuoka, Fukuoka 819-0373, Japan

Fukuoka, Fukuoka 8190167, Japan

Kasuga-shi, Fukuoka 816-0802, Japan

Minokamo-shi, Gifu 505-8510, Japan

Kiryu-shi, Gunma 376-0024, Japan

Maebashi, Gunma 371-8511, Japan

Fukuyama-shi, Hiroshima 721-8511, Japan

Asahikawa-shi, Hokkaido 078-8510, Japan

Sapporo, Hokkaido 003-0026, Japan

Sapporo, Hokkaido 003-0833, Japan

Sapporo, Hokkaido 060-0033, Japan

Amagasaki-shi, Hyōgo 660-8511, Japan

Amagasaki-shi, Hyōgo 660-8550, Japan

Kobe, Hyōgo 650-0017, Japan

Isehara-shi, Kanagawa 259-1193, Japan

Kawasaki-shi, Kanagawa 211-0063, Japan

Kawasaki-shi, Kanagawa 211-8533, Japan

Yokohama, Kanagawa 222-0036, Japan

Kumamoto, Kumamoto 862-0950, Japan

Nagasaki, Nagasaki 852-8501, Japan

Nagaoka-shi, Niigata 940-2085, Japan

Daito-shi, Osaka 574-0046, Japan

Neyagawa, Osaka 572-0838, Japan

Shizuoka, Shizuoka 420-8527, Japan

Adachi-ku, Tokyo 120-0034, Japan

Chuo-ku, Tokyo 103-0028, Japan

Chuo-ku, Tokyo 103-0031, Japan

Chuo-ku, Tokyo 104-0031, Japan

Itabashi-ku, Tokyo 173-8610, Japan

Minato-ku, Tokyo 108-0014, Japan

Nakano-ku, Tokyo 164-0001, Japan

Nakano-ku, Tokyo 165-0026, Japan

Ōta-ku, Tokyo 114-0052, Japan

Ōta-ku, Tokyo 143-0013, Japan

Ōta-ku, Tokyo 1430023, Japan

Setagaya-ku, Tokyo 158-0097, Japan

Tachikawa-shi, Tokyo 1900023, Japan

Toyama, Toyama 930-8550, Japan